Evaluation of the Efficacy of a Homeopathic Protocol in Patients With Non-metastatic Breast Cancer
-
- STATUS
- Recruiting
-
- participants needed
- 140
-
- sponsor
- Institut Jean-Godinot
Summary
Interventional, randomised, prospective, monocentric study
Description
Interventional, randomised, prospective, monocentric study
Primary objective :
Demonstrate the interest of the homeopathic Protocol to reduce the onset or aggravation of joint pain as a result of the taking of AI compared to conventional care
Secondary objective :
Compare between the two treatment groups:
- Evolution of joint pain
- Evolution of joint stiffness-rate of onset of pain and joint stiffness-delay in onset or aggravation of pain-evolution of the number of painful locations-evolution of the impact of pain on the quality of the sleep-consumption of permitted concomitant treatments (analgesics)
- Evolution of symptoms of hormonal deprivation-adherence to AI treatment
- Tolerance to AI
- Change seen by patients
- Stop rate and switch of AI-rate of recurrence of breast cancer
Describe in patients receiving homeopathic treatment:
- Adherence to homeopathic treatment
- Tolerance to homeopathic treatment
- Group A: Group of patients receiving conventional treatment (drug analgesic class 1) for joint pain + homeopathic treatment
- Group B: Group of patients receiving conventional treatment (drug analgesic class 1) for joint pain
Schedule :
- Inclusions start at: 01/09/2018
- End date of inclusions: 01/09/2020 (duration to possibly adapt in order to obtain the number of required patients)
- End date of follow-up: 01/03/2021
- Study report: 01/09/2021
Details
| Condition | Arthralgia, Pain, Pain, Breast Cancer Female |
|---|---|
| Age | 18-100 years |
| Treatment | Rhus toxicodendron 9 CH + Ruta graveolens 5 CH (Homeopathic Granules), paracetamol (drug analgesic class1) |
| Clinical Study Identifier | NCT04408560 |
| Sponsor | Institut Jean-Godinot |
| Last Modified on | 19 February 2024 |
How to participate?
,
You have contacted , on
Your message has been sent to the study team at ,
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting
Primary Contact
Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.
Learn moreIf you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Learn moreComplete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.
Learn moreSimilar trials to consider
Browse trials for
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteer
Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!
No annotations made yet
Add a private note
- Select a piece of text from the left.
- Add notes visible only to you.
- Send it to people through a passcode protected link.
Study Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.